← Back to headlines
Moderna and Merck's mRNA Cancer Vaccine Shows Continued Promise
A new mRNA cancer vaccine developed by Merck & Co. and Moderna Inc. continues to show promise in preventing melanoma recurrence, with a recent breakthrough suggesting it could usher in a new era of cancer vaccines.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
